G2K Injection contains Pantoprazole 40mg, a proton pump inhibitor used to reduce stomach acid production. It is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and other conditions involving excessive gastric acid secretion. Pantoprazole works by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing the final step in acid production. This leads to a significant and prolonged reduction in gastric acid secretion, promoting healing of acid-related damage and relief from symptoms such as heartburn and acid regurgitation. G2K Injection is typically administered intravenously in hospital settings for patients who cannot take oral medication or require rapid acid suppression. The dosage and duration of treatment depend on the specific condition being treated and the patient’s clinical response. Common side effects may include headache, diarrhea, nausea, and abdominal pain, though it is generally well tolerated. Caution is advised in patients with liver impairment, and long-term use should be monitored to avoid potential complications such as vitamin B12 deficiency or bone fractures. G2K Injection offers an effective solution for managing acid-related gastrointestinal disorders under medical supervision.